UA85239C2 - Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity - Google Patents
Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivityInfo
- Publication number
- UA85239C2 UA85239C2 UAA200613783A UAA200613783A UA85239C2 UA 85239 C2 UA85239 C2 UA 85239C2 UA A200613783 A UAA200613783 A UA A200613783A UA A200613783 A UAA200613783 A UA A200613783A UA 85239 C2 UA85239 C2 UA 85239C2
- Authority
- UA
- Ukraine
- Prior art keywords
- art
- relates
- imidazole derivatives
- disclosed
- manufacture
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention relates to 1,2,4,5-tetrasubstituted imidazole derivatives as selective cannabinoid CBreceptor modulators, in particular СВreceptor antagonists or inverse agonists having a high CB/CBreceptor subtype selectivity, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said imidazole derivatives. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. A beneficial effect is disclosed herein or apparent to a person skilled in the art from the specification and general knowledge in the art. The invention also relates to the use of a compound of the invention for the manufacture of a medicament for treating or preventing a disease or condition. More particularly, the invention relates to a new use for the treatment of a disease or condition disclosed herein or apparent to a person skilled in the art from the specification and general knowledge in the art. In embodiments of the invention specific compounds disclosed herein are used for the manufacture of a medicament useful in the treatment of psychiatric and neurological disorders. The compounds have the general formula (I) wherein the symbols have the meanings given in the specification., (I)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04076619 | 2004-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA85239C2 true UA85239C2 (en) | 2009-01-12 |
Family
ID=34928258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200613783A UA85239C2 (en) | 2004-05-28 | 2005-05-26 | Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN1956965B (en) |
| AR (1) | AR052763A1 (en) |
| SA (1) | SA05260148B1 (en) |
| TW (1) | TW200608968A (en) |
| UA (1) | UA85239C2 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI231757B (en) * | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
-
2005
- 2005-05-24 TW TW094116864A patent/TW200608968A/en unknown
- 2005-05-24 AR ARP050102138 patent/AR052763A1/en not_active Application Discontinuation
- 2005-05-25 SA SA05260148A patent/SA05260148B1/en unknown
- 2005-05-26 UA UAA200613783A patent/UA85239C2/en unknown
- 2005-05-26 CN CN2005800162950A patent/CN1956965B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1956965A (en) | 2007-05-02 |
| CN1956965B (en) | 2011-03-23 |
| SA05260148B1 (en) | 2008-11-15 |
| AR052763A1 (en) | 2007-04-04 |
| TW200608968A (en) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176547A0 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity | |
| HK1092152A1 (en) | Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof | |
| UA87856C2 (en) | Alkynyl derivatives as modulators of metatropic glutamate receptors | |
| ATE453620T1 (en) | AZETIDINE CARBOXAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF CB1 RECEPTOR-MEDIATED DISEASES | |
| MXPA04002583A (en) | Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity. | |
| GB0510143D0 (en) | Novel compounds A1 | |
| PL367814A1 (en) | 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity | |
| NO20064238L (en) | Imidazoline derivatives with CB1 agonist activity | |
| WO2004013120A8 (en) | Novel benzodioxoles | |
| HRP20080587T3 (en) | Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity | |
| FR2817256B1 (en) | DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND ITS SUPERIOR APPROACHES AS GAMMA-HYDROXYBUTYRATE (GHB) RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES | |
| UA85239C2 (en) | Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity | |
| DE60224509D1 (en) | IMIDAZOLE DERIVATIVES USE AS HISTAMINE H3 RECEPTOR LIGANDS | |
| ATE496896T1 (en) | 1H-IMIDAZOLE DERIVATIVES AS MODULATORS OF THE CANNABINOID RECEPTOR | |
| UA84594C2 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives as cb1 antagonists | |
| UA84737C2 (en) | Imidazoline derivatives having cb1-antagonistic activity |